Two possible mechanisms underlying nitrate tolerance in monkey coronary arteries

Clinical and Experimental Pharmacology and Physiology

Volumn 28, Issue 4, 2001, Pages 259-265

  Omura, Tomoko ^a   Matsumoto, Tetsuya ^a   Nakae, Ichiro ^a   Takahashi, Masayuki ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Atrial natriuretic peptide; Cyclic GMP; Monkey; Nitric oxide; Nitroglycerin

Indexed keywords

8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; FORSKOLIN; GLYCERYL TRINITRATE; GUANYLATE CYCLASE ACTIVATOR; ISOBUTYLMETHYLXANTHINE; NITRATE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PAPAVERINE; PROSTAGLANDIN F2 ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG CROSS TOLERANCE; DRUG TOLERANCE; DRUG TRANSFORMATION; FEMALE; ISOLATED ARTERY; MALE; MONKEY; NONHUMAN; VASODILATATION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CORONARY VESSELS; CYCLIC GMP; DRUG INTERACTIONS; DRUG TOLERANCE; FEMALE; MACACA; MALE; NITRATES; NITRIC OXIDE; NITROGLYCERIN; NITROPRUSSIDE; VASODILATION; VASODILATOR AGENTS;

EID: 0035089247     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2001.03436.x     Document Type: Article

References (45)

1. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of s-nitrosothiols as active intermediates
2. Cyclic guanosine monophosphate as a mediator of vasodilation
3. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase
4. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
5. Mechanism of glyceryl trinitrate-induced vasodilation. 1. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta
6. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines
7. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine
8. Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10 000 × g supernatant: Biotransformation and nitric oxide formation
9. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle
10. Mechanism of tolerance development to organic nitrate
11. Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production: Probes with inhibitors and tolerance development
12. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissue
13. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle
14. Effects of atrial natriuretic peptide on proximal epicardial coronary arteries and coronary blood flow in conscious dogs
15. Effects of atrial natriuretic peptide on the coronary vasculature in humans
16. Effects of synthetic human atrial natriuretic peptide on the coronary circulation in subjects with normal ventricular function
17. Vascular atrial natriuretic factor receptor subtypes are not independently regulated by atrial peptides
18. Down-regulation of atrial natriuretic peptide receptor and cyclic GMP response in cultured rat vascular smooth muscle cells
19. Vascular smooth muscle relaxation by nitro compounds. Reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol
20. Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle
21. Effects of glyceryl trinitrate on endothelium-dependent and -independent relaxation and cyclic GMP levels in rat aorta and human coronary artery
22. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade
23. Studies on vascular smooth muscle tolerance to different cGMP-mediated vasodilators and cross-tolerance to glyceryl trinitrate
24. Studies of the desensitization of arterial natriuretic factor and nitroglycerin in rat aortic rings
25. Interaction of nitrovasodilators and atrial natriuretic peptide in isolated dog coronary arteries
26. Vasorelaxing effect of atrial and brain natriuretic peptides on coronary circulation in heart failure
27. Interactions of nitrovasodilators, atrial natriuretic peptide and endothelium-derived nitric oxide
28. The action of vasodilating drugs on isolated basilar, coronary and mesenteric arteries of the dog
29. Studies on relaxation of rabbit aorta by sodium nitrite: The basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide
30. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta
31. Mechanisms of nitrate tolerance
32. Influence of methylene blue and oxyhemoglobin on mammalian vascular responses to sodium nitroprusside and nitroglycerin
33. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion
34. Endothelium-derived relaxing factor
35. Is nitric oxide the only endothlium-derived relaxing factor in canine femoral veins?
36. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure
37. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function
38. Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina
39. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris
40. Coronary hemodynamic effects of atrial natriuretic peptide in humans
41. Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris
42. Cardiovascular and adenylate cyclase stimulant properties of NKH477, a novel water-soluble forskolin derivative
43. The role of cyclic AMP in mesenteric vasodilation
44. Vasorelaxing effect of s-nitrosocaptopril on dog coronary arteries: NO cross-tolerance with nitroglycerin
45. Renal effects of nitric oxide donor, NOC7, in anesthetized rabbits